Martina Delle Fave

Martina Delle Fave

Auto-generated profile, based on publicly available information

Martina Delle Fave

Service d'ophtalmologie, université Libre de Bruxelles, hôpital Erasme, route de Lennik, 808, 1070 Bruxelles (Anderlecht), Belgique

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2021 in Ophthalmic Genetics
Verified
Journal Article
Closed access
MFM. Delle Fave
M. Delle Fave
MCM. Cordonnier
M. Cordonnier
LVL. Vallee
L. Vallee
CCC. Condroyer
C. Condroyer
CZC. Zeitz
C. Zeitz
IBI. Balikova
I. Balikova
The complete form of congenital stationary night blindness (cCSNB) represents a non-progressive retinal disorder characterized by night vision problems and often congenital nystagmus, reduced vision, high myopia, strabismus and normal fundus appearance. Clinically this form of CSNB can be diagnosed by full-field electroretinogram. The mode of inheritance can be X-linked and autosomal recessive with mutations in genes coding for proteins mainly present at the dendritic tips of ON-bipolar cells. Mutations in NYX, GRM6, GPR179, LRIT3 and TRPM1 lead to this condition. The latter gene defect represents the major form underlying cCSNBC. It codes for the melastatin-related transient receptor 1 expressed in the inner nuclear layer of the retina, with the protein localized in ON-bipolar cells. To date, various homozygous or compound heterozygous mutations in TRPM1 have been reported. Small chromosomal rearrangements are frequent cause of mental retardation. In rare cases deletions can overlap with a mutation on the remaining chromosome and lead to a recessive disorder. Here, we describe a patient with mild neurological deficiencies and cCSNB caused by a microdeletion on 15q32 overlapping with a TRPM1 variant.

1 March 2021 in Journal Français d'Ophtalmologie
Verified
Journal Article
Closed access
MFM. Delle Fave
M. Delle Fave
MCM. Cordonnier
M. Cordonnier
MPM. Polyanina
M. Polyanina
OKO. Kallay
O. Kallay

1 January 2014 in BioMed Research International
Verified
Journal Article
Open access
APAndrea Perdicchi
Andrea Perdicchi
GPGiacomo Peluso
Giacomo Peluso
DIDaniela Iacovello
Daniela Iacovello
MBMarco Balestrieri
Marco Balestrieri
MFMartina Delle Fave
Martina Delle Fave
SRSanti Maria Recupero
Santi Maria Recupero
Purpose. To detect the effects of intravitreal ranibizumab injections on GCC in patients with wet AMD.Methods. 32 wet AMD eyes were selected and submitted at three ranibizumab injections. RTVue-OCT GCC and MM5 protocol were performed before treatment and twenty days after each injection.Results. At baseline mean GCC thickness was 93.9 ± 18.5 μm. Twenty days after each intravitreal injection it was, respectively, 85.8 ± 10.1, 86.5 ± 9.3, and 91.1 ± 11.5 μm, without statistical significance. A significant improvement in visual acuity (P= 0.031) and a reduction of mean foveal (P= 0.001) and macular thickness (P= 0.001) were observed.Conclusion. The clinical results confirm therapeutic efficacy of intravitreal injections of ranibizumab in wet AMD. A contemporary not statistically significant reduction of GCC thickness suggests that the loading phase of ranibizumab does not have any toxic effects on ganglion cell complex.

1 June 2021 in Journal Français d'Ophtalmologie
Verified
Journal Article
Closed access
CBC. Ballez
C. Ballez
MFM. Delle Fave
M. Delle Fave
YMY. Alaoui Mhamedi
Y. Alaoui Mhamedi
PDP. Delvaulx
P. Delvaulx
ABA. Bostan
A. Bostan